From the Department of Cell Biology, Tokyo Metropolitan Institute of
Gerontology (M.Y., M.A., N.F., K.Y.), and the Department of Neurosurgery,
Tokyo Medical and Dental University (M.A., Y.M.), Tokyo, Japan.
Correspondence to Kiyotaka Yamamoto, PhD, Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology, 352 Sakae-cho, Itabashi-ku, Tokyo 173, Japan. E-mail kyama{at}tmig.or.jp
Background and PurposeMoyamoya
disease is a progressive cerebrovascular occlusive disease affecting
primarily children. The etiology remains unknown. We examined the
chemotactic and proliferative activities of inflammatory cell
products from arterial smooth muscle cells (SMCs)
derived from moyamoya patients and compared them with those from
control subjects.
MethodsWe used 12 SMC strains from moyamoya patients and
eight from control subjects. SMC migration was examined in a micro
chemotaxis chamber. DNA synthesis was measured by an immunoperoxidase
technique.
ResultsPlatelet-derived growth factor (PDGF)-BB markedly
stimulated cell migration and DNA synthesis in control SMCs. PDGF-AA
stimulated only DNA synthesis in control SMCs. In moyamoya SMCs,
PDGF-AA and PDGF-BB stimulated cell migration but not DNA synthesis.
Basic fibroblast growth factor had little migratory activity but
stimulated DNA synthesis in moyamoya SMCs and control SMCs.
Conversely, hepatocyte growth factor stimulated cell
migration but not DNA synthesis in moyamoya SMCs and control SMCs.
In contrast, interleukin-1ß (IL-1ß) significantly stimulated the
migration and DNA synthesis of control SMCs, while it inhibited
moyamoya SMC migration. The levels of IL-1ßinduced nitric oxide
production did not differ between moyamoya SMCs and control
SMCs, suggesting that IL-1ß inhibits the migration of moyamoya
SMCs through a nitric oxideindependent pathway.
ConclusionsThe differences in responses to PDGF and IL-1 in
moyamoya SMCs are involved in the mechanism by which intimal
thickening develops in moyamoya disease.
© 1998 American Heart Association, Inc.
Original Contributions
Differences in Cellular Responses to Mitogens in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease
Key Words: cytokines growth factors moyamoya disease muscle, smooth
This article has been cited by other articles:
![]() |
M. Bonduel, M. Hepner, G. Sciuccati, A. F. Torres, S. Tenembaum, and G. de Veber Prothrombotic Disorders in Children With Moyamoya Syndrome Editorial Comment Stroke, August 1, 2001; 32(8): 1786 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, M. Aoyagi, N. Fukai, Y. Matsushima, and K. Yamamoto Increase in Prostaglandin E2 Production by Interleukin-1{beta} in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease Circ. Res., November 12, 1999; 85(10): 912 - 918. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |